Logo image of IMNN

IMUNON INC (IMNN) Stock Price, Quote, News and Overview

NASDAQ:IMNN - Nasdaq - US15117N6022 - Common Stock - Currency: USD

2.8398  +0.35 (+14.05%)

IMNN Quote, Performance and Key Statistics

IMUNON INC

NASDAQ:IMNN (6/2/2025, 11:03:54 AM)

2.8398

+0.35 (+14.05%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High3.65
52 Week Low0.37
Market Cap41.52M
Shares14.62M
Float14.40M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-12 2025-08-12
IPO10-27 1993-10-27


IMNN short term performance overview.The bars show the price performance of IMNN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 100 200 300 400

IMNN long term performance overview.The bars show the price performance of IMNN in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of IMNN is 2.8398 USD. In the past month the price increased by 196.43%. In the past year, price increased by 72.92%.

IMUNON INC / IMNN Daily stock chart

IMNN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.04 327.28B
AMGN AMGEN INC 13.86 154.70B
GILD GILEAD SCIENCES INC 13.73 132.24B
VRTX VERTEX PHARMACEUTICALS INC N/A 113.48B
REGN REGENERON PHARMACEUTICALS 10.99 52.59B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 39.24B
ARGX ARGENX SE - ADR 99.62 34.97B
BNTX BIONTECH SE-ADR N/A 27.41B
ONC BEONE MEDICINES LTD-ADR 6.26 26.44B
NTRA NATERA INC N/A 21.66B
BIIB BIOGEN INC 8.22 19.05B
UTHR UNITED THERAPEUTICS CORP 12.9 14.58B

About IMNN

Company Profile

IMNN logo image Imunon, Inc. is a clinical stage oncology drug company. The company is headquartered in Lawrenceville, New Jersey and currently employs 25 full-time employees. The firm is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases, constituting a differentiating approach from conventional therapies. The firm is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the gene-based delivery of cytokines and other therapeutic proteins in the treatment of solid tumors. The second modality, PlaCCine, is developed for the gene delivery of viral antigens that can elicit a strong immunological response. The Company’s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer that has completed Phase 2 development. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site.

Company Info

IMUNON INC

997 Lenox Dr Ste 100

Lawrenceville NEW JERSEY US

Employees: 25

IMNN Company Website

IMNN Investor Relations

Phone: 16098969100

IMUNON INC / IMNN FAQ

What is the stock price of IMUNON INC today?

The current stock price of IMNN is 2.8398 USD. The price increased by 14.05% in the last trading session.


What is the ticker symbol for IMUNON INC stock?

The exchange symbol of IMUNON INC is IMNN and it is listed on the Nasdaq exchange.


On which exchange is IMNN stock listed?

IMNN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for IMUNON INC stock?

10 analysts have analysed IMNN and the average price target is 13.87 USD. This implies a price increase of 388.49% is expected in the next year compared to the current price of 2.8398. Check the IMUNON INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is IMUNON INC worth?

IMUNON INC (IMNN) has a market capitalization of 41.52M USD. This makes IMNN a Nano Cap stock.


How many employees does IMUNON INC have?

IMUNON INC (IMNN) currently has 25 employees.


Should I buy IMUNON INC (IMNN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does IMUNON INC (IMNN) stock pay dividends?

IMNN does not pay a dividend.


When does IMUNON INC (IMNN) report earnings?

IMUNON INC (IMNN) will report earnings on 2025-08-12.


What is the Price/Earnings (PE) ratio of IMUNON INC (IMNN)?

IMUNON INC (IMNN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.48).


What is the Short Interest ratio of IMUNON INC (IMNN) stock?

The outstanding short interest for IMUNON INC (IMNN) is 7.07% of its float. Check the ownership tab for more information on the IMNN short interest.


IMNN Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to IMNN. When comparing the yearly performance of all stocks, IMNN is one of the better performing stocks in the market, outperforming 98.51% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IMNN Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to IMNN. While IMNN seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IMNN Financial Highlights

Over the last trailing twelve months IMNN reported a non-GAAP Earnings per Share(EPS) of -1.48. The EPS increased by 26.73% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -259.3%
ROE -3936.55%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%46.15%
Sales Q2Q%N/A
EPS 1Y (TTM)26.73%
Revenue 1Y (TTM)-100%

IMNN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 82% to IMNN. The Buy consensus is the average rating of analysts ratings from 10 analysts.


Ownership
Inst Owners2.93%
Ins Owners1.14%
Short Float %7.07%
Short Ratio10.06
Analysts
Analysts82
Price Target13.87 (388.41%)
EPS Next Y20.81%
Revenue Next YearN/A